Literature DB >> 6420203

Ovarian function in amenorrheic and menstruating users of a levonorgestrel-releasing intrauterine device.

C G Nilsson, P L Lähteenmäki, T Luukkainen.   

Abstract

The ovarian function of 20 healthy users of a levonorgestrel-releasing intrauterine device was studied by measurements of plasma estradiol, progesterone, and levonorgestrel concentrations. Eight subjects were amenorrheic, and 12 had regular menstrual bleeding. Seventy-five percent of the subjects in both groups had ovulatory cycles. There was no difference between the mean levonorgestrel concentrations in the amenorrheic and regularly menstruating subjects. Estradiol function was undisturbed in the amenorrheic subjects with ovulatory cycles. The effect of levonorgestrel as a cause of amenorrhea is thought to be mainly of local nature. The intrauterine administration of levonorgestrel had only an occasional and weak effect on ovarian function.

Entities:  

Keywords:  Amenorrhea--etiology; Biology; Contraception; Contraceptive Agents, Female--analysis; Contraceptive Agents, Progestin; Contraceptive Agents--analysis; Contraceptive Methods; Diseases; Endocrine System; Endometrial Effects; Endometrium; Estradiol--analysis; Estrogens; Examinations And Diagnoses; Family Planning; Genitalia; Genitalia, Female; Hormones; Iud; Iud, Hormone Releasing; Laboratory Procedures; Levonorgestrel--analysis; Menstruation; Menstruation Disorders; Ovarian Effects; Ovary; Physiology; Progestational Hormones; Progesterone--analysis; Reproduction; Reproductive Control Agents; Reversibility; Size; Urogenital System; Uterus

Mesh:

Substances:

Year:  1984        PMID: 6420203

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  13 in total

1.  Study on in vivo release of levonorgestrel-containing silicon capsule.

Authors:  C J Wu; X R Wu; W J Xia; R L Li
Journal:  J Tongji Med Univ       Date:  1995

Review 2.  A risk-benefit assessment of the levonorgestrel-releasing intrauterine system.

Authors:  F Sturridge; J Guillebaud
Journal:  Drug Saf       Date:  1996-12       Impact factor: 5.606

3.  Effect of domestically-made levonorgestrel-releasing intrauterine device on the endocrine system and menstruation in monkeys.

Authors:  C Wu; W Xia; X Wu; R Li; X Huang; Y Yan; D Huang
Journal:  J Tongji Med Univ       Date:  1996

4.  Levonorgestrel hormone releasing intrauterine system (Mirena) as a contraceptive in egg donors: case report.

Authors:  C Kailasam; V Akande; U D Gordon
Journal:  J Assist Reprod Genet       Date:  2005-03       Impact factor: 3.412

5.  Impact of Combined Hormonal Contraceptive Use on Weight Loss: A Secondary Analysis of a Behavioral Weight-Loss Trial.

Authors:  Ann E Caldwell; Adnin Zaman; Danielle M Ostendorf; Zhaoxing Pan; Bryan B Swanson; Suzanne Phelan; Holly R Wyatt; Daniel H Bessesen; Edward L Melanson; Victoria A Catenacci
Journal:  Obesity (Silver Spring)       Date:  2020-06       Impact factor: 5.002

6.  Benefit-risk assessment of the levonorgestrel intrauterine system in contraception.

Authors:  Tiina Backman
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

7.  Safety, efficacy and patient acceptability of the contraceptive and non-contraceptive uses of the LNG-IUS.

Authors:  Paula H Bednarek; Jeffrey T Jensen
Journal:  Int J Womens Health       Date:  2010-08-09

8.  Safety and efficacy in parous women of a 52-mg levonorgestrel-medicated intrauterine device: a 7-year randomized comparative study with the TCu380A.

Authors:  Patrick Rowe; Tim Farley; Alexandre Peregoudov; Gilda Piaggio; Simone Boccard; Sihem Landoulsi; Olav Meirik
Journal:  Contraception       Date:  2016-02-23       Impact factor: 3.375

9.  Intrauterine devices and endometrial cancer risk: a pooled analysis of the Epidemiology of Endometrial Cancer Consortium.

Authors:  Ashley S Felix; Mia M Gaudet; Carlo La Vecchia; Christina M Nagle; Xiao Ou Shu; Elisabete Weiderpass; Hans Olov Adami; Shirley Beresford; Leslie Bernstein; Chu Chen; Linda S Cook; Immaculata De Vivo; Jennifer A Doherty; Christine M Friedenreich; Susan M Gapstur; Dierdre Hill; Pamela L Horn-Ross; James V Lacey; Fabio Levi; Xiaolin Liang; Lingeng Lu; Anthony Magliocco; Susan E McCann; Eva Negri; Sara H Olson; Julie R Palmer; Alpa V Patel; Stacey Petruzella; Jennifer Prescott; Harvey A Risch; Lynn Rosenberg; Mark E Sherman; Amanda B Spurdle; Penelope M Webb; Lauren A Wise; Yong-Bing Xiang; Wanghong Xu; Hannah P Yang; Herbert Yu; Anne Zeleniuch-Jacquotte; Louise A Brinton
Journal:  Int J Cancer       Date:  2014-09-30       Impact factor: 7.316

Review 10.  Understanding benefits and addressing misperceptions and barriers to intrauterine device access among populations in the United States.

Authors:  Jennie Yoost
Journal:  Patient Prefer Adherence       Date:  2014-07-03       Impact factor: 2.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.